Swiss Biotech Launches Amidst Hot Streak for Rare Autoimmune Disease
Swiss biotech Chord Therapeutics launched this week with a €13.7M Series A, becoming the latest…
Swiss biotech Chord Therapeutics launched this week with a €13.7M Series A, becoming the latest…
The Swedish firm Cartana and US-based ReadCoor have recently been snapped up by the US…
The biotech community is raving about the long-anticipated recognition of the groundbreaking CRISPR-Cas9 gene editing…
The European Investment Bank (EIB) is backing a huge €250M fund to help bioeconomy companies…
The last month has seen several big investments in European neuromodulation and neurostimulation companies, which…
The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the…
The Netherlands-based food technology company Mosa Meats has raised €62M in a Series B round…
UK-based investment firm Medicxi aims to attract more investors to the life sciences with a…
AC Immune and Genentech’s drug has failed to slow the progression of Alzheimer’s disease in…
Roche’s acquisition of the Irish biotech Inflazome is a vote of confidence for emerging inflammatory…
3D printing has revolutionized manufacturing by reducing costs and giving designers and engineers immense flexibility.…
The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a…